The Chemours Company has reached a settlement exceeding $450 million with the U.S. Department of Justice (DOJ), Environmental Protection Agency (EPA), and West Virginia environmental authorities to address contamination linked to its production of per- and polyfluoroalkyl substances (PFAS), often referred to as “forever chemicals.”
This comprehensive agreement covers four Chemours facilities located in West Virginia, New Jersey, and North Carolina, where alleged PFAS discharges have raised serious environmental and health concerns. The settlement includes a civil penalty of $22.5 million and commits Chemours to invest $280 million in supplying clean drinking water to affected communities surrounding its plants in West Virginia and New Jersey.
Chemours will also direct $90 million towards programs designed to reduce PFAS emissions and will spend approximately $60 million upgrading pollution control technologies at its West Virginia facility. While specific investments for the North Carolina plant are still being evaluated, the company has pledged to consider measures for reducing PFAS and other toxic releases there. These actions aim to prevent future contamination while allowing Chemours to continue manufacturing PFAS for essential commercial and military applications where substitutes remain limited.
The settlement is governed under multiple federal and state laws, including the Clean Water Act, Resource Conservation and Recovery Act, Toxic Substances Control Act, and West Virginia Water Pollution Control Act. It stands as the federal government’s first broad enforcement resolution with a major manufacturer over PFAS pollution.
PFAS are a group of synthetic chemicals valued for resistance to water, grease, and stains but have gained notoriety for persistence in the environment and potential health risks. The EPA reports widespread PFAS contamination across all fifty states, often linked to industrial releases, including manufacturing sites like those operated by Chemours.
In announcing the settlement, DOJ officials highlighted the importance of balancing ongoing production of critical PFAS materials with robust environmental safeguards. Chemours described the agreement as a key advance in its “Pathway to Thrive” strategy, which focuses on long-term environmental responsibility and addressing legacy PFAS issues.